LOCK-UP AGREEMENTOmega Fund III, L.P. • November 10th, 2014 • Pharmaceutical preparations • New York
Reference is hereby made to that certain Agreement and Plan of Merger and Reorganization, dated as of June 30, 2014 (as the same may be amended from time to time, the “Merger Agreement”), by and among Transcept Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Tigris Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Tigris, Tigris Acquisition Sub, LLC, a Delaware limited liability company, and Paratek Pharmaceuticals, Inc., a Delaware corporation. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement.
JOINT FILING AGREEMENTJoint Filing Agreement • November 10th, 2014 • Omega Fund III, L.P. • Pharmaceutical preparations
Joint Filing Agreement, dated as of November 10, 2014, is by and among the various reporting persons that are listed in the signature blocks below (the “Omega Filers”).
